Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults

Clinical trial NCT07331545 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07331545
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatohepatitis(MASH)

Start date: 2026-01-01
Primary completion: 2026-07-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.